What was the overall market valuation of the Japan aesthetics market in 2024?

The overall market valuation was $148.93 Million in 2024. Read More

What is the projected market valuation for the Japan aesthetics market by 2035?

The projected valuation for 2035 is $399.5 Million. Read More

What is the expected CAGR for the Japan aesthetics market during the forecast period 2025 - 2035?

The expected CAGR during the forecast period 2025 - 2035 is 9.38%. Read More

Which segments contributed to the Japan aesthetics market's performance?

The segments include Invasive Procedures, Non-invasive Procedures, Male, Female, Clinics, Hospitals, Medical Spas, Beauty Centers, and Home Care. Read More

What were the valuations for invasive and non-invasive procedures in 2024?

In 2024, invasive procedures were valued at $45.0 Million, while non-invasive procedures were valued at $103.93 Million. Read More

How do male and female segments compare in the Japan aesthetics market?

In 2024, the male segment was valued at $44.47 Million, whereas the female segment was valued at $104.46 Million. Read More

What is the market size for clinics, hospitals, and medical spas in 2024?

The market size for clinics, hospitals, and medical spas was $60.0 Million in 2024. Read More

What are the projected valuations for beauty centers and home care by 2035?

By 2035, beauty centers are projected to reach $130.0 Million, and home care is expected to reach $109.5 Million. Read More

Who are the key players in the Japan aesthetics market?

Key players include Allergan, Galderma, Revance Therapeutics, Medytox, Ipsen, Hugel, and Sientra. Read More

What trends are expected to shape the Japan aesthetics market in the coming years?

Trends may include increased demand for non-invasive procedures and a growing focus on male aesthetics. Read More

Japan Aesthetics Market

Japan Aesthetics Market Research Report By Procedure (Invasive Procedures, Non-invasive Procedures), By Invasive Procedures (Breast Augmentation, Liposuction, Nose Reshaping, Eyelid Surgery, Tummy Tuck, Others), By Non-invasive Procedures (Botox Injections, Soft Tissue Fillers, Chemical Peel, Laser Hair Removal, Microdermabrasion, Others), By Gender (Male, Female) and By End-User (Clinics, Hospitals, and Medical Spas, Beauty Centers, Home Care) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

9.38%

2024 Market Size

$ 148.93 Million

2035 Market Size

$ 399.5 Million

Healthcare ● Updated April 2026 Report ID: MRFR/HC/13156-HCR | Pages: 135 | Author: Satyendra Maurya, Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Life Sciences, BY Procedure (USD Million) | |
  1. 4.1.1 Invasive Procedures | |
  2. 4.1.2 Non-invasive Procedures |
2. 4.2 Life Sciences, BY Gender (USD Million) | |
  1. 4.2.1 Male | |
  2. 4.2.2 Female |
3. 4.3 Life Sciences, BY End-User (USD Million) | |
  1. 4.3.1 Clinics, Hospitals, and Medical Spas | |
  2. 4.3.2 Beauty Centers | |
  3. 4.3.3 Home Care 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Life Sciences | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Allergan (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Galderma (CH) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Revance Therapeutics (US) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Medytox (KR) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Ipsen (FR) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Hugel (KR) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Medytox (KR) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Sientra (US) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 Hugel (KR) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 JAPAN MARKET ANALYSIS BY PROCEDURE |
6. 6.3 JAPAN MARKET ANALYSIS BY GENDER |
7. 6.4 JAPAN MARKET ANALYSIS BY END-USER |
8. 6.5 KEY BUYING CRITERIA OF LIFE SCIENCES |
9. 6.6 RESEARCH PROCESS OF MRFR |
10. 6.7 DRO ANALYSIS OF LIFE SCIENCES |
11. 6.8 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES |
12. 6.9 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES |
13. 6.10 SUPPLY / VALUE CHAIN: LIFE SCIENCES |
14. 6.11 LIFE SCIENCES, BY PROCEDURE, 2024 (% SHARE) |
15. 6.12 LIFE SCIENCES, BY PROCEDURE, 2024 TO 2035 (USD Million) |
16. 6.13 LIFE SCIENCES, BY GENDER, 2024 (% SHARE) |
17. 6.14 LIFE SCIENCES, BY GENDER, 2024 TO 2035 (USD Million) |
18. 6.15 LIFE SCIENCES, BY END-USER, 2024 (% SHARE) |
19. 6.16 LIFE SCIENCES, BY END-USER, 2024 TO 2035 (USD Million) |
20. 6.17 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
21. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
22. 7.2 Japan MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY PROCEDURE, 2025-2035 (USD Million) | |
  2. 7.2.2 BY GENDER, 2025-2035 (USD Million) | |
  3. 7.2.3 BY END-USER, 2025-2035 (USD Million) |
23. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.3.1 |
24. 7.4 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

Japan Aesthetics Market Segmentation

Japan Aesthetics Market By Procedure (USD Million, 2025-2035)

Invasive Procedures
Non-invasive Procedures

Japan Aesthetics Market By Gender (USD Million, 2025-2035)

Male
Female

Japan Aesthetics Market By End-User (USD Million, 2025-2035)

Clinics, Hospitals, and Medical Spas
Beauty Centers
Home Care

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”